[Secondary choroidal neovascularization-Really so common?]

IF 0.6 Die Ophthalmologie Pub Date : 2025-03-01 Epub Date: 2025-02-10 DOI:10.1007/s00347-025-02197-8
Ulrike Brocks, Martin Ziegler, Clemens Lange, Lebriz Altay, Laurenz Pauleikhoff
{"title":"[Secondary choroidal neovascularization-Really so common?]","authors":"Ulrike Brocks, Martin Ziegler, Clemens Lange, Lebriz Altay, Laurenz Pauleikhoff","doi":"10.1007/s00347-025-02197-8","DOIUrl":null,"url":null,"abstract":"<p><p>The occurrence of secondary choroidal neovascularization (CNV) is a complication in patients with chronic central serous chorioretinopathy. The diagnosis is made using multimodal imaging. The treatment usually includes intravitreal anti-vascular endothelial growth factor (VEGF) injections. A combination with photodynamic therapy can be useful; however, the response to anti-VEGF treatment is significantly reduced compared to other indications for CNV, so that an irreversible decrease of visual acuity often remains.</p>","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"196-200"},"PeriodicalIF":0.6000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Die Ophthalmologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00347-025-02197-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/10 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The occurrence of secondary choroidal neovascularization (CNV) is a complication in patients with chronic central serous chorioretinopathy. The diagnosis is made using multimodal imaging. The treatment usually includes intravitreal anti-vascular endothelial growth factor (VEGF) injections. A combination with photodynamic therapy can be useful; however, the response to anti-VEGF treatment is significantly reduced compared to other indications for CNV, so that an irreversible decrease of visual acuity often remains.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
继发性脉络膜新生血管——真的那么普遍吗?]
继发性脉络膜新生血管(CNV)的发生是慢性中枢性浆液性脉络膜视网膜病变患者的并发症。诊断采用多模态成像。治疗通常包括玻璃体内注射抗血管内皮生长因子(VEGF)。结合光动力疗法是有用的;然而,与CNV的其他适应症相比,抗vegf治疗的反应明显降低,因此视力往往会出现不可逆的下降。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Pronounced band keratopathy in panuveitis]. [Corneal crosslinking for keratoconus: real-life data and Committee for Refractive Surgery (KRC) recommendations]. [Imaging: new techniques for imaging of the vitreous body]. [Recurrence of herpetic eye disease following cataract surgery: risk factors and prevention]. [Remodeling of the internal retina-Implications for targeted optogenetics].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1